No Data
No Data
Xilong Scientific: Half-year report for the year 2024.
Xilong Scientific: Summary of Half-Year Report in 2024.
Xilong Scientific (002584.SZ): The net income for the first half of the year was 42.7086 million yuan, with a year-on-year growth of 240.24%.
Xilong Scientific (002584.SZ) announced its semi-annual report for 2024, with operating revenue of 4.447 billion yuan, a year-on-year growth of 21.16%; net income attributable to shareholders of the listed company was 42.7086 million yuan, a year-on-year growth of 240.24%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 41.1832 million yuan, a year-on-year growth of 556.78%; basic earnings per share was 0.07 yuan.
Investors More Bullish on Xilong Scientific (SZSE:002584) This Week as Stock Hikes 13%, Despite Earnings Trending Downwards Over Past Five Years
Xilong Scientific: 2024 Interim Performance Forecast
Xilong Scientific (002584.SZ): net income in the first half of the year is expected to increase by 154.93%-258.49%.
On July 8th, GeLongHui reported that Xilong Scientific (002584.SZ) is expected to achieve a net income of 32 million to 45 million yuan attributable to shareholders of listed companies in the first half of 2024, an increase of 154.93%-258.49% compared to the same period last year; deducting non-recurring gains and losses, it is expected to achieve a net income of 30 million to 40 million yuan, an increase of 378.43%-537.91% compared to the same period last year; basic earnings per share are expected to be 0.05 yuan/share-0.08 yuan/share. The net profit attributable to shareholders of listed companies increased year-on-year in the first half of 2024.
No Data